Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Finding of Mean Corpuscular Hemoglobin
|
1206 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Heart failure
|
201 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hypercholesterolemia, Familial
|
1423 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Hyperlipoproteinemia Type IIa
|
661 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Leukopenia
|
153 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Neoplasm, Residual
|
23 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Neoplasms
|
1644 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Neutropenia
|
97 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
progesterone receptor-negative breast cancer
|
11 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
progesterone receptor-positive breast cancer
|
17 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Psoriasis
|
705 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Renal Insufficiency
|
42 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Sex hormone binding globulin measurement
|
21 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Squamous cell carcinoma
|
257 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Thrombocytopenia
|
110 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Thyroxine measurement
|
42 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Uric acid measurement (procedure)
|
1463 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2019 | 2019 |